Scholarlink

Background <p>Consumer engagement in medical research should be early, ongoing, and meaningful, to improve patient-centred research design and outcomes. Evaluating the impact of consumer input builds the evidence base needed to sustain and improve ongoing involvement efforts. Multiple evaluation tools are available. Here we explore the landscape of evaluation tools and apply the Australian Clinical Trials Alliance (ACTA) tool to evaluate the impact and process of consumer involvement in a recently completed project.</p> Methods <p>The ACTA evaluation tool was administered to all consumers and research team members in the “RECAP” study. The RECAP study is co-designed as a single-arm trial that implemented registry-generated personalised care plans for patients with newly diagnosed rectal cancer. The ACTA evaluation tool responses underwent thematic analysis, and the research and consumer group assessed the utility of the tool.</p> Results <p>The ACTA evaluation tool was completed by the entire team, including six consumers and four researchers. Thematic analysis highlighted inclusivity, workload, communication and remuneration as key considerations in the process of consumer involvement. Consumer impact was measured in terms of seven domains of critical research outcomes. Consumer involvement in the RECAP project was identified to be meaningful, respectful, inclusive, and impactful. The evaluation tool was considered appropriate by all respondents, who identified the ease of use, low burden and ability to address both the consumer impact and experience as positive factors. Identified areas for development included the repetitiveness and lack of specify of some questions, and the uncertainty about the desired length of response.</p> Conclusion <p>The ACTA evaluation tool was successfully administered to a team of consumers and researchers engaged in a recently completed trial with positive assessment of tool utility.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stronger together; evaluating consumers and researchers working in partnership

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月1日

查看全文
  • Grace Gard,
  • Joanna Oakley,
  • Kelsey Serena,
  • Michael Harold,
  • Katya Gray,
  • Helen Anderson,
  • Judi Byrne,
  • Jo Cockwill,
  • Jim Cormack,
  • Graeme Down,
  • George Kiossoglou,
  • Peter Gibbs

摘要

Background

Consumer engagement in medical research should be early, ongoing, and meaningful, to improve patient-centred research design and outcomes. Evaluating the impact of consumer input builds the evidence base needed to sustain and improve ongoing involvement efforts. Multiple evaluation tools are available. Here we explore the landscape of evaluation tools and apply the Australian Clinical Trials Alliance (ACTA) tool to evaluate the impact and process of consumer involvement in a recently completed project.

Methods

The ACTA evaluation tool was administered to all consumers and research team members in the “RECAP” study. The RECAP study is co-designed as a single-arm trial that implemented registry-generated personalised care plans for patients with newly diagnosed rectal cancer. The ACTA evaluation tool responses underwent thematic analysis, and the research and consumer group assessed the utility of the tool.

Results

The ACTA evaluation tool was completed by the entire team, including six consumers and four researchers. Thematic analysis highlighted inclusivity, workload, communication and remuneration as key considerations in the process of consumer involvement. Consumer impact was measured in terms of seven domains of critical research outcomes. Consumer involvement in the RECAP project was identified to be meaningful, respectful, inclusive, and impactful. The evaluation tool was considered appropriate by all respondents, who identified the ease of use, low burden and ability to address both the consumer impact and experience as positive factors. Identified areas for development included the repetitiveness and lack of specify of some questions, and the uncertainty about the desired length of response.

Conclusion

The ACTA evaluation tool was successfully administered to a team of consumers and researchers engaged in a recently completed trial with positive assessment of tool utility.